The Wisconsin Legislature has introduced Assembly Joint Resolution 32, which designates the first full week in May as Tardive Dyskinesia Awareness Week. This resolution highlights the significant impact of tardive dyskinesia (TD), a condition that can arise from the prolonged use of antipsychotic medications, which are often necessary for managing serious mental illnesses such as bipolar disorder and schizophrenia. The resolution emphasizes that many individuals at risk for TD, particularly those over 55, Black individuals, and those with certain mental health conditions, remain undiagnosed, with approximately 60% of the estimated 800,000 adults in the U.S. living with TD unaware of their condition.

The resolution calls for increased awareness and education regarding TD among healthcare providers, patients, and caregivers, advocating for routine screenings as recommended by the American Psychiatric Association. By designating a specific week for awareness, the Wisconsin Legislature aims to improve early detection and intervention, ultimately enhancing the quality of life for those affected by TD. The resolution underscores the importance of addressing the stigma associated with TD symptoms and ensuring that individuals receiving antipsychotic treatment are adequately supported and monitored for this condition.